ERBB2 and breast carcinoma: In 2018, Leong and co-workers engineered a mesoporous silica-gold nanocluster hybrid nanozymes with excellent peroxidase-like catalytic activity for selective detection of HER2-positive (HER2+) breast cancer cell (Li et al., 2019).